 |
|
|
| |
PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF DOLUTEGRAVIR/RILPIVIRINE (JULUCA) IN HEALTHY JAPANESE ADULTS
|
| |
| |
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs Virtual Meeting, September 28-30, 2020
Reported by Jules Levin
Mehta R,1 Butcher L,2 Seal C,2 Zhai K,2 Aylott A,3 Thompson A,3 Wynne B,4 Crauwels H,5 Adkison K4
1GlaxoSmithKline, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Upper Providence, PA, USA; 3GlaxoSmithKline, Uxbridge, UK; 4ViiV Healthcare, Research Triangle Park, NC, USA; 5Janssen Pharmaceutical Companies, Beerse, Belgium
|
| |
|
|
|
|
|
